U.S. markets closed

Axcella Health Inc. (AXLA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.1500-0.1700 (-3.94%)
At close: 4:00PM EDT
4.1500 0.00 (0.00%)
After hours: 05:20PM EDT

Axcella Health Inc.

840 Memorial Drive
3rd Floor
Cambridge, MA 02139
United States
857 320 2200
http://www.axcellahealth.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees59

Key Executives

NameTitlePayExercisedYear Born
Mr. William R. Hinshaw Jr.Pres, CEO & Director812.05kN/A1969
Mr. Laurent ChardonnetSr. VP & CFO576.06kN/A1965
Mr. Jason FredetteVP of Investor Relations & Corp. CommunicationsN/AN/AN/A
Dr. Paul Fehlner J.D., Ph.D.Sr. VP, Chief Legal Officer & Corp. Sec.N/AN/A1964
Dr. Larry BellGlobal Head of Regulatory Affairs & Pharmacovigilance and Sr. VPN/AN/AN/A
Dr. Alison D. Schecter M.D.Pres of R&DN/AN/A1964
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. It treats complex diseases and enhances health using endogenous metabolic modulator compositions. The company's lead product candidates include AXA1665 for the treatment of overt hepatic encephalopathy; and AXA1125 for treating non-alcoholic steatohepatitis. It also develops AXA4010, a hematology product candidate; and AXA2678, a muscle product candidate. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

Corporate Governance

Axcella Health Inc.’s ISS Governance QualityScore as of June 1, 2021 is 9. The pillar scores are Audit: 5; Board: 9; Shareholder Rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.